title: mTOR inhibitors: a myth, a cure for cancer or something in between?
authors.forename: G
authors.initials: G
authors.lastname: Wong
authors.forename: J R
authors.initials: JR
authors.lastname: Chapman
authors.forename: J C
authors.initials: JC
authors.lastname: Craig
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D020123:Sirolimus / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus